“PHARMACOLOGIC TOPOISOMERASE-I INHIBITION CAUSES DNA DAMAGE AND MORTALITY IN ACTIVATED CD4+ T CELLS”, GenApp, vol. 2, no. 2, pp. 51–56, Dec. 2018, doi: 10.31383/ga.vol2iss2pp51-56.